All VTI Articles

VTI Shares New Findings from its PROTECT Study of the NaturalVue Multifocal Contact Lens

sponsored content December 16, 2024 Recently discovered findings continue emerging from the PROTECT RCT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) being conducted by Visioneering...

108

Review of Myopia Management Hosts THE Myopia Meeting in Markham/Greater Toronto Area

December 9, 2024 MARKHAM, Ontario, Canada – On Sunday, December 8, leaders in the eye care field gathered here for THE Myopia...

100

Practice Profiles

My High Myopia Complications Led to My Passion for Helping Others

November 15, 2024 By Joseph Munsell, OD I was first introduced to myopia management in optometry school at Pacific University, though it...

253

VTI Shares Latest One-Year PROTECT Trial Data at Academy 2024

November 12, 2024 INDIANAPOLIS — At the American Academy of Optometry Meeting, Visioneering Technologies Inc. (VTI) shared new findings from Year One...

528

VTI’s Chief Medical Officer Dr. Ashley Tuan Shares PROTECT Study Data at IMC

sponsored content October 15, 2024 SANYA, Hainan Island, China – Dr. Ashley Tuan, OD, PhD, the Chief Medical Officer of Visioneering Technologies,...

354

VTI Presents Latest PROTECT Trial Data at Myopia Conferences

October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT...

594

Currently Available Myopia Control Soft Lenses: How Do They Compare?

September 3, 2024 By Rebecca Dang, BOptom/BSci (Hons), MOptom Soft myopia control contact lenses (CLs) present an effective intervention for progressing myopes,1...

676

Gelflex Named Australia and New Zealand Distributor of NaturalVue Multifocals

August 22, 2024 ATLANTA, Ga./PERTH, Australia — Visioneering Technologies Inc. (VTI) has announced Gelflex as the official distributor of its NaturalVue Multifocal...

2.4K

Treating Myopia Progression in Teens

sponsored content July 15, 2024 By Ilana Gelfond-Polnariev, OD, FOVDR When I put my teen patients into NaturalVue Enhanced Multifocals, which are...

976

Surprising Results with NaturalVue Multifocals with Astigmatic Kids

sponsored content June 3, 2024 Visioneering Technologies, Inc.’s (VTI) NaturalVue Multifocal 1 day contact lenses have been shown to be safe and...

721

Practice Profiles

Talking About Your Passions Builds Myopia Management Success

May 15, 2024 By Arthur Jung, OD I have such a passion for myopia, and that’s clear in how I communicate with...

1.3K

VTI Shares Latest Data From PROTECT Study at ARVO 2024

May 6, 2024 SEATTLE, Wash. — Visioneering Technologies Inc. has shared the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for...

773

Talking to Parents About Myopia Gets More Pediatric Patients in My Office Chair

April 15, 2024 By Jamie Brosof, OD The first step in our office is starting the conversation about myopia management with my...

1.2K

Podcasts

New Data and Fitting Experience Revealed for VTI’s NaturalVue Multifocal Contact Lenses

sponsored content April 3, 2024 In this interview, Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies Inc. (VTI) sat down...

882

VTI’s Dr. Ashley Tuan Shares PROTECT Study’s One-Year Results

sponsored content March 4, 2024 In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the...

794

VTI Shares Ongoing Results of One-Year PROTECT Trial

January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...

783

PROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control

sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...

591

Dr. Ashley Tuan Discusses VTI’s PROTECT Trial

sponsored content October 17, 2023 Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies...

774

Juan Carlos Aragón Discusses His New CEO Role at Visioneering Technologies

sponsored content October 12, 2023 At the American Academy of Optometry’s Annual Meeting, Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Dr. Juan...

781

VTI Shares One-Year Data from PROTECT Trial at AAO 2023

October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...

1.3K

VTI’s NaturalVue Six-Year Data Confirmed by Three Independent Studies

September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...

1.9K

VTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director

ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...

1.1K

Podcasts

Up Close With: GMAC’s Layna Mendlinger and Nitin Jain

May 15, 2023 This year’s new co-chairs of the Marketing Committee for the Global Myopia Awareness Coalition (GMAC) are Layna Mendlinger, Global...

3.7K

Myopia Management Efficacy Comparison: OrthoK vs. Peripheral Defocus Contact Lenses

May 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Many therapies for myopia management have been studied and are currently...

2.4K